Mirae Asset Global Investments’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $152K | Buy |
4,613
+683
| +17% | +$22.6K | ﹤0.01% | 1081 |
|
|
2025
Q1 | $170K | Sell |
3,930
-3
| -0.1% | -$130 | ﹤0.01% | 1071 |
|
|
2024
Q4 | $186K | Sell |
3,933
-323
| -8% | -$15.3K | ﹤0.01% | 1056 |
|
|
2024
Q3 | $223K | Buy |
4,256
+833
| +24% | +$43.6K | ﹤0.01% | 1071 |
|
|
2024
Q2 | $184K | Sell |
3,423
-56,000
| -94% | -$3.01M | ﹤0.01% | 1056 |
|
|
2024
Q1 | $2.33M | Buy |
59,423
+5,676
| +11% | +$223K | 0.01% | 1127 |
|
|
2023
Q4 | $4.49M | Buy |
53,747
+2,063
| +4% | +$172K | 0.01% | 925 |
|
|
2023
Q3 | $1.52M | Buy |
51,684
+359
| +0.7% | +$10.6K | ﹤0.01% | 1308 |
|
|
2023
Q2 | $1.68M | Sell |
51,325
-10,399
| -17% | -$339K | ﹤0.01% | 1297 |
|
|
2023
Q1 | $2.17M | Buy |
61,724
+8,565
| +16% | +$301K | 0.01% | 1172 |
|
|
2022
Q4 | $2.44M | Buy |
53,159
+16,117
| +44% | +$738K | 0.01% | 1055 |
|
|
2022
Q3 | $1.8M | Buy |
37,042
+11,441
| +45% | +$554K | ﹤0.01% | 1183 |
|
|
2022
Q2 | $1.01M | Buy |
+25,601
| New | +$1.01M | ﹤0.01% | 1397 |
|